NO20034588D0 - Fremgangsmåter og midler for anvendelse av HLA-DQ- restringerte T-cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider - Google Patents

Fremgangsmåter og midler for anvendelse av HLA-DQ- restringerte T-cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider

Info

Publication number
NO20034588D0
NO20034588D0 NO20034588A NO20034588A NO20034588D0 NO 20034588 D0 NO20034588 D0 NO 20034588D0 NO 20034588 A NO20034588 A NO 20034588A NO 20034588 A NO20034588 A NO 20034588A NO 20034588 D0 NO20034588 D0 NO 20034588D0
Authority
NO
Norway
Prior art keywords
hla
restricted
agents
methods
cell receptors
Prior art date
Application number
NO20034588A
Other languages
English (en)
Other versions
NO20034588L (no
Inventor
Jan Wouter Drijfhout
Frits Koning
Stephan Neil Mcadam
Ludvig Magne Sollid
Original Assignee
Academisch Ziekenhuis Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academisch Ziekenhuis Leiden filed Critical Academisch Ziekenhuis Leiden
Publication of NO20034588D0 publication Critical patent/NO20034588D0/no
Publication of NO20034588L publication Critical patent/NO20034588L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20034588A 2001-04-12 2003-10-13 Materialer og metoder for anvendelse av HLA-DQ-restringerte T- cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider NO20034588L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01201377 2001-04-12
EP01204383 2001-11-16
PCT/NL2002/000235 WO2002083722A2 (en) 2001-04-12 2002-04-11 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides

Publications (2)

Publication Number Publication Date
NO20034588D0 true NO20034588D0 (no) 2003-10-13
NO20034588L NO20034588L (no) 2003-12-10

Family

ID=26076879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034588A NO20034588L (no) 2001-04-12 2003-10-13 Materialer og metoder for anvendelse av HLA-DQ-restringerte T- cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider

Country Status (7)

Country Link
US (1) US20040241161A1 (no)
EP (1) EP1377604B1 (no)
CA (1) CA2443886A1 (no)
IL (1) IL158342A0 (no)
MX (1) MXPA03009313A (no)
NO (1) NO20034588L (no)
WO (1) WO2002083722A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923306D0 (en) 1999-10-01 1999-12-08 Isis Innovation Diagnostic and therapeutic epitope, and transgenic plant
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
AU2003215272B2 (en) * 2002-02-14 2008-04-03 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
US7776545B2 (en) 2002-11-20 2010-08-17 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic method for Celiac Sprue
GB0212885D0 (en) * 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof
AU2005237287B2 (en) 2004-04-28 2011-08-11 Btg International Limited Epitopes related to coeliac disease
US10105437B2 (en) 2004-04-28 2018-10-23 Btg International Limited Epitopes related to coeliac disease
AU2011247868B2 (en) * 2004-04-28 2014-05-22 Btg International Limited Epitopes related to coeliac disease
EP1612558A1 (en) * 2004-06-30 2006-01-04 Academisch Ziekenhuis Leiden Method for detecting gluten
CA2645674A1 (en) * 2006-03-15 2007-09-20 Isocell Pharma S.A. Pharmaceutical compositions comprising sods and prolamine based peptide fragments
WO2008090126A1 (de) * 2007-01-22 2008-07-31 N-Zyme Biotec Gmbh Getränke für zöliakiepatienten und gluten/gliadin-sensitive personen und verfahren zur herstellung
US20090311727A1 (en) * 2008-04-21 2009-12-17 Bio-Rad Laboratories, Inc. Recombinant deamidated gliadin antigen
HUE027237T2 (en) 2008-11-30 2016-10-28 Immusant Inc Compositions and methods for treatment of celiac disease
FR2942409B1 (fr) * 2009-02-20 2013-07-26 Natacha Voillot Composition pharmaceutique pour la prevention des avortements a repetition.
JP2014508517A (ja) * 2011-02-08 2014-04-10 ファディア・アクチボラゲット 小麦誘発過敏症診断用の小麦抗原およびペプチド
CA2857177C (en) 2011-12-05 2020-06-23 Bio-Rad Laboratories, Inc. Recombinant deamidated gliadin antigen
CA2923822A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
CA2962933A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease
US20200040085A1 (en) * 2017-02-27 2020-02-06 Chugai Seiyaku Kabushiki Kaisha Anti-hla-dq2.5/8 antibody and its use for the treatment of celiac disease
GB201802338D0 (en) 2018-02-13 2018-03-28 Univ Oslo Antigen binding proteins
KR20230116942A (ko) 2020-09-18 2023-08-04 추가이 세이야쿠 가부시키가이샤 항hla-dq2.5 항체 및 셀리악병의 치료를 위한 그의사용

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0905518A1 (en) * 1997-09-23 1999-03-31 Academisch Ziekenhuis Leiden Peptides specific for gluten-sensitive T-cells and use thereof
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement

Also Published As

Publication number Publication date
EP1377604B1 (en) 2014-12-31
WO2002083722A2 (en) 2002-10-24
EP1377604A2 (en) 2004-01-07
WO2002083722A3 (en) 2003-02-06
IL158342A0 (en) 2004-05-12
US20040241161A1 (en) 2004-12-02
NO20034588L (no) 2003-12-10
MXPA03009313A (es) 2004-11-12
CA2443886A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
NO20034588D0 (no) Fremgangsmåter og midler for anvendelse av HLA-DQ- restringerte T-cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider
NO20033387D0 (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
IL168058A0 (en) Antibodies that bind celi-associated ca 125/0722p and methods of use thereof
IS7499A (is) Mennsk mótefni gegn beta-amýloíðpeptíðum
NO20012937D0 (no) Direkte spröytestöpt lukking og fremgangsmåte for denne
DK1620456T3 (da) Hla-a2 tumor-associerede antigen-peptider og præparater
ATE480567T1 (de) Hochkonzentrierter antikörper und proteinformulierungen
IL200608A0 (en) Methods for the detection of 193p1e1b protein and use of compositions containing a 193p1e1b protein or an antibody binding thereto
DK1372686T3 (da) Fremgangsmåder og sammensætninger til peptidsyntese
ATE412013T1 (de) Anti-osteopontin-antikörper und dessen verwendung
AU2002340167A8 (en) Anti-hla-dr antibodies and the methods of using thereof
AU2002362586A1 (en) Receptors and membrane-associated proteins
AU2002364699A8 (en) Receptors and membrane-associated proteins
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
AU2003222225A8 (en) Receptors and membrane-associated proteins
AU2002309970A8 (en) Receptors and membrane-associated proteins
AU2003276844A8 (en) Formulations of modified antibodies and methods of making the same
AU2002326910A1 (en) Receptors and membrane-associated proteins
NO20042500L (no) Chemokin-reseptorantagonister og metoder for anvendelse derav
AU2003272799A8 (en) Receptors and membrane-associated proteins
AU2003262895A8 (en) Carboxypeptidase b related polypeptides and methods of use
AU2003295437A8 (en) Receptors and membrane-associated proteins
AU2003260487A8 (en) Novel pancortin-pablo protein interactions and methods of use thereof
AU2003269884A8 (en) Receptors and membrane-associated proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application